# Respiratory System & Pulmonology

## Respiratory Tract Embryology Stages

|Mnemonic|Stage|
|-|-|
|Empty|Embryonic|
|Pockets|Pseudoglandular|
|Can|Canalicular|
|Store|Saccular|
|Air|Alveolar|

## Lung Volumes

![](../Figures/Lung%20Volumes.png)

## Perfusion and Diffusion Limited Pulmonary Circulation

![](../Figures/Perfusion%20and%20Diffusion%20Limited%20Pulmonary%20Circulation.png)

## Etiology of Hypoxemia

- A-a gradient :: normal
	- V/Q ratio :: normal
		- **Altitude sickness**
	- V/Q ratio :: mismatch
		- **Neuromuscular diseases**
		- **Airway obstruction**
		- **Obstructive lung diseases**
		- **Restrictive lung diseases** :: extrinsic
		- **Metabolic alkalosis**
- A-a gradient :: high
	- V/Q ratio :: normal
		- **Pulmonary consolidation**
		- **Restrictive lung diseases** :: intrinsic
		- **Right-to-left shunt**
	- V/Q ratio :: mismatch
		- **Pulmonary consolidation**
		- **Pulmonary embolism**
		- **Hepatopulmonary syndrome**

## Etiology of Kussmaul Breathing {KUSSMAUL}

- Ketoacidosis
- Uremia
- Sepsis
- Salicylate
- Methanol
- Aldehyde
- Uricemia
- Lactic acidosis

## Light Criteria for Pleural Fluid (PF)

|PF|PF ÷ Serum Protein Ratio|PF ÷ Serum LDH Ratio|PF LDH|
|-|-|-|-|
|Transudate|< 0.5|< 0.6|< 2/3 Serum LDH upper limit|
|Exudate|> 0.5|> 0.6|> 2/3 Serum LDH upper limit|

## Classification of Asthma Severity

|Asthma|Attacks|Awakenings|SABA Uses|Activity Limitation|FEV<sub>1</sub>|FEV<sub>1</sub>/FVC|
|-|-|-|-|-|-|-|
|Intermittent|< 2 days/week|≤ 2/month|≤2 days/week|None|Normal|Normal|
|Mild persistent|2 ~ 7 days/week|3 ~ 4/month|2 ~ 7 days/week|Minor|> 80%|Normal|
|Moderate persistent|Daily|> 1/week|Daily|Some|60 ~ 80%|↓ < 5%|
|Severe persistent|Throughout|Daily|Throughout|Extreme|< 60%|↓ > 5%|

## Treatment of Asthma

![](../Figures/Treatment%20of%20Asthma.gif)

## Mechanisms of Action of Medications for Asthma

|Mechanism|Medication|Indications|
|-|-|-|
|β<sub>2</sub> agonists|Albuterol|Asthma :: acute|
||Salmeterol & Formoterol|Asthma :: chronic|
|M antagonists|Ipratropium & Tiotropium|Asthma|
|NF-κB inhibitors|Steroids|Asthma|
|LOX inhibitors|Zileuton|Asthma|
|LTD<sub>4</sub> antagonists|Montelukast|Asthma|
||Zafirlukast|Asthma|
|Mast cell inhibitors|Cromolyn|Asthma|
||Nedocromil|Asthma|
|IgE inhibitors|Omalizumab|Asthma|
